Keywords
Skin biopsy
Primary Health Care
Early diagnosis
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the indications, techniques, and contributions of performing skin biopsies in primary health care for the early diagnosis of skin cancer. Literature review: Skin cancer is the most prevalent neoplasm in Brazil, representing approximately 30% of all malignant tumors. The definitive diagnosis depends on performing a skin biopsy with histopathological analysis, considered the gold standard. Despite being a low-complexity outpatient procedure, its execution remains concentrated in specialized services within the Brazilian Unified Health System (SUS), which may result in diagnostic delays and worse prognosis. The literature shows that PHC physicians have the technical competence to perform shave, punch, incisional, and excisional biopsies. Decentralizing this procedure can reduce waiting time, healthcare costs, and morbidity and mortality associated with late diagnosis. Final considerations: The systematic incorporation of skin biopsy into PHC represents a viable strategy aligned with SUS principles, contributing to greater effectiveness of care and strengthening early diagnosis of skin cancer.
References
AGUIRE PC, et al. Skin biopsy techniques. UpToDate, 2024.
APALLA Z, et al. Skin cancer: epidemiology, disease burden, pathophysiology, diagnosis, and therapeutic approaches. Dermatology and Therapy (Heidelberg), 2017; 7(Suppl 1): 5-19.
BEARD CJ, et al. Excisional biopsy. StatPearls Publishing, 2025.
BONFIM SS, et al. Câncer de pele: conhecendo e prevenindo a população. Revista Científica Sena Aires, 2018; 7(3): 255-259.
BRAY F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer Journal for Clinicians, 2018; 68(6): 394-424.
CRAYTHORNE E, AL-NIAMI F. Skin cancer. Medicine, 2017; 45(7): 431-434.
FILHO NETO AVR, et al. Perfil epidemiológico de pacientes portadores de câncer de pele atendidos no Hospital Regional da Asa Norte/DF – Brasil. Revista Brasileira de Cirurgia Plástica, 2020; 35(3): 1-6.
INCA. ABC do câncer: abordagens básicas para o controle do câncer. Rio de Janeiro: Instituto Nacional de Câncer, 2011.
INCA. Câncer de pele não melanoma. Instituto Nacional de Câncer, 2022.
INCA. Estimativa 2020: incidência de câncer no Brasil. Rio de Janeiro: Instituto Nacional de Câncer, 2019.
INCA. Pele não melanoma (taxas brutas). Instituto Nacional de Câncer, 2022.
KHAMPARIA A, et al. An internet of health things-driven deep learning framework for detection and classification of skin cancer using transfer learning. Transactions on Emerging Telecommunications Technologies, 2020; 3963.
KHAN NH, et al. Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures. Journal of Advanced Research, v. 36, p. 223–247, 2022. https://doi.org/10.1016/j.jare.2021.06.014
KOK Y, et al. The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma. Australasian Journal of Dermatology, v. 62, n. 4, p. e524–e531, 2021. DOI: 10.1111/ajd.13697
KOPKE LFL. Biópsias orientadas em oncologia cutânea. Surgical and Cosmetic Dermatology, 2014; 6(1): 77-81.
LOPES CH, LEITE AKRMF. Fatores de risco, patogenia e aspectos clínicos do melanoma no Brasil: uma revisão integrativa. Revista de Patologia do Tocantins, 2021; 8(3): 125-129.
MINISTÉRIO DA EDUCAÇÃO. Resolução CNRM nº 9, de 30 de dezembro de 2020. Diário Oficial da União, 2020.
PICKETT H. Shave and punch biopsy for skin lesions. American Family Physician, 2011; 84(9): 995-1002.
RAMSEY ML, ROSTAMI S. Biópsia de pele. StatPearls Publishing, 2025.
TADIPARTHI S, et al. Biopsy for malignant melanoma: are we following the guidelines? Annals of the Royal College of Surgeons of England, 2008; 90(4): 322-325.
WERNER B. Biópsia de pele e seu estudo histológico: por quê? para quê? como? Parte I. Anais Brasileiros de Dermatologia, 2009; 84(4): 395-405.
WERNER B. Biópsia de pele e seu estudo histológico: por quê? para quê? como? Parte II. Anais Brasileiros de Dermatologia, 2009; 84(5): 507-513.